Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvonne Paterson

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2006
When it comes to CTL recognition, size does matterYvonne Paterson
Immunologic Research|July 15, 2003
Rational approaches to immune regulationYvonne Paterson
Expert Review of Vaccines|May 11, 2013
Live-attenuated Listeria-based immunotherapyJohn Rothman, Yvonne Paterson
Vaccine|February 1, 2003
Enhancing the immunogenicity of bioengineered Listeria monocytogenes by passaging through live animal hostsChristian Peters, Yvonne Paterson
Immunological Investigations|August 19, 2006
Effects of the tumor microenvironment on the efficacy of tumor immunotherapyPaul Neeson, Yvonne Paterson
Expert Review of Vaccines|September 23, 2006
Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapyReshma Singh, Yvonne Paterson
Cancer Biology & Therapy|February 9, 2010
Harnessing Listeria monocytogenes to target tumorsClaudia Gravekamp, Yvonne Paterson
Cancer Research|March 3, 2007
Immunoediting sculpts tumor epitopes during immunotherapyReshma Singh, Yvonne Paterson
Cancer Research|August 4, 2006
Vaccination strategy determines the emergence and dominance of CD8+ T-cell epitopes in a FVB/N rat HER-2/neu mouse model of breast cancerReshma Singh, Yvonne Paterson
Cancer Immunology, Immunotherapy : CII|November 30, 2006
In the FVB/N HER-2/neu transgenic mouse both peripheral and central tolerance limit the immune response targeting HER-2/neu induced by Listeria monocytogenes-based vaccinesReshma Singh, Yvonne Paterson
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2006
When it comes to CTL recognition, size does matterYvonne Paterson
Immunologic Research|July 15, 2003
Rational approaches to immune regulationYvonne Paterson
Expert Review of Vaccines|May 11, 2013
Live-attenuated Listeria-based immunotherapyJohn Rothman, Yvonne Paterson
Vaccine|February 1, 2003
Enhancing the immunogenicity of bioengineered Listeria monocytogenes by passaging through live animal hostsChristian Peters, Yvonne Paterson
Immunological Investigations|August 19, 2006
Effects of the tumor microenvironment on the efficacy of tumor immunotherapyPaul Neeson, Yvonne Paterson
Expert Review of Vaccines|September 23, 2006
Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapyReshma Singh, Yvonne Paterson
Cancer Biology & Therapy|February 9, 2010
Harnessing Listeria monocytogenes to target tumorsClaudia Gravekamp, Yvonne Paterson
Cancer Research|March 3, 2007
Immunoediting sculpts tumor epitopes during immunotherapyReshma Singh, Yvonne Paterson
Cancer Research|August 4, 2006
Vaccination strategy determines the emergence and dominance of CD8+ T-cell epitopes in a FVB/N rat HER-2/neu mouse model of breast cancerReshma Singh, Yvonne Paterson
Cancer Immunology, Immunotherapy : CII|November 30, 2006
In the FVB/N HER-2/neu transgenic mouse both peripheral and central tolerance limit the immune response targeting HER-2/neu induced by Listeria monocytogenes-based vaccinesReshma Singh, Yvonne Paterson
Pageof 8